(National Laboratory Astana, NAZARBAYEV UNIVERSITY, 2016-05) Zhalbinova, M.; Rakhimova, S.; Bekbosynova, M.; Myrzakhmetova, Sh.; Akilzhanova, A.
Warfarin is an oral anticoagulant which is popular in cardiology for the prevention
and treatment of thromboembolic events in patients with deep vein thrombosis. Patients usually
treated according to the clinical data. However, incorrect dose of the treatment can be followed
with side effects such as excessive bleeding and thrombosis. To avoid these side effects
patients need genetic tests for specific genes which are responsible for the sensitivity of patient
to warfarin. GGCX is one of the genes which have a role in dose of the warfarin